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Introduction
Nanoparticle (NP) interactions with proteins and other molecules within the biological
milieu have been termed the nano-bio interface. This new field has created great excitement within the biomaterials and engineering community.1–7 Recently, the anticancer
activity of zinc oxide (ZnO) NPs has been shown by our group and several others and is
now considered a nanoscale chemotherapeutic.8–10 Furthermore, the antibacterial activity
of ZnO NPs has recently been linked to its ability to serve as a biomimetic inhibitor of
the beta-galactosidase enzyme.11 Indeed nickel oxide (NiO), magnesium oxide (MgO)
and ZnO possess some inherent catalytic activity themselves.12–14 Strikingly, NiO NPs
have been shown to restore the function of fragmented enzyme that is nonfunctional in
solution.3 Thus, the biochemical activity of physiological metal oxide NPs including
4523
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Introduction: Biomedical applications of nanoparticles (NPs) as enzyme inhibitors have recently
come to light. Oxides of metals native to the physiological environment (eg, Fe, Zn, Mg, etc.)
are of particular interest—especially the functional consequences of their enzyme interaction.
Materials and methods: Here, Fe2O3, zinc oxide (ZnO), magnesium oxide (MgO) and nickel
oxide (NiO) NPs are compared to copper (Cu) and boron carbide (B4C) NPs. The functional
impact of NP interaction to the model enzyme luciferase is determined by 2-dimensional fluorescence difference spectroscopy (2-D FDS) and 2-dimensional photoluminescence difference
spectroscopy (2-D PLDS). By 2-D FDS analysis, the change in maximal intensity and in 2-D FDS
area under the curve (AUC) is in the order Cu~B4C.ZnO.NiO..Fe2O3.MgO. The induced
changes in protein conformation are confirmed by tryptic digests and gel electrophoresis.
Results: Analysis of possible trypsin cleavage sites suggest that cleavage mostly occurs in the
range of residues 112–155 and 372–439, giving a major 45 kDa band. By 2-D PLDS, it is found
that B4C NPs completely ablate bioluminescence, while Cu and Fe2O3 NPs yield a unique bimodal
negative decay rate, −7.67×103 and −3.50×101 relative light units respectively. Cu NPs, in particular, give a remarkable 271% change in enzyme activity. Molecular dynamics simulations in
water predicted that the surfaces of metal oxide NPs become capped with metal hydroxide groups
under physiological conditions, while the surface of B4C becomes populated with boronic acid
or borinic acid groups. These predictions are supported by the experimentally determined zeta
potential. Thin layer chromatography patterns further support this conception of the NP surfaces,
where stabilizing interactions were in the order ionic.polar.non-polar for the series tested.
Conclusion: Overall the results suggest that B4C and Cu NP functional dynamics on enzyme
biochemistry are unique and should be examined further for potential ramifications on other
model, physiological or disease-relevant enzymes.
Keywords: 2-dimensional fluorescence difference, 2-D FDS, AUC, corrected light intensity
emitted, emission wavelength, excitation wavelength, wavelength of max intensity, RLU
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zinc, iron, magnesium and others and their functional impact
on enzymes are of tremendous interest but have never before
been directly compared. Furthermore, studies on some NP
compositions suggest that boron carbide (B4C) NPs may disturb RNA–protein interactions and that copper (Cu) NPs may
strongly influence protein secondary structure, yet the effect of
these NPs on biochemical activity remains unexplored.15,36
What is known about NP–protein interaction is based primarily on transport proteins or those which are highly prevalent in blood such as albumin.7,15–19 In these cases, a variety of
different techniques were employed to investigate NP–protein
interaction, including (but not limited to) circular dichroism
(CD), Raman, far UV and infrared spectroscopy, as well as
isothermal calorimetry.15–19,20 Fluorescence spectroscopy tends
to be more quantitative,16 and fluorescence difference spectroscopy (FDS) has been used to investigate changes in protein
conformation and adsorption to the surface of derivatized
silica.21 Interaction of ZnO NPs with fibrinogen, globulins and
albumin resulted in a marked change in the tryptophan (Trp)
emission spectra compared to the same proteins in solution or
in contact with other NPs.17 Luciferase (Luc) is often used as a
model enzyme whose structure22–26 is such that the fluorescence
of Trp moieties in the hinge region flanking its active site provide a sensitive probe of conformational changes.27,28 Two-dimensional spectroscopy (performed by independent scanning
of excitation and emission frequencies) provides an excellent
quantitative measure with which to compare conformational
changes induced by various NPs upon their interaction to Luc.
In concert with the effects of NPs on protein conformation,
interaction of NPs with enzymes has been shown to stabilize,
activate or inhibit them.11,29–32 In addition to fluorescence, the
exquisite sensitivity of the bioluminescence produced by Luc
and its detection by photoluminescence (PL) spectroscopy have
been widely exploited in biotechnology and more recently in
nanobiotechnology.3,4,29,35 Bioluminescence resonance energy
transfer between Luc and NPs may be a potential means of amplifying and increasing signal to noise in biosensor applications.4,33–35
Mapping the bioluminescence difference spectra in 2-dimensions (excitation and emission) provides an excellent quantitative measure with which activity changes induced by various
NPs upon their interaction with Luc can be compared. More
importantly, area under the curve (AUC) analysis of the kinetics
provides a new way to compare the functional impact of NP.

Materials and methods
Materials
ZnO NPs obtained from Dr G Glaspell (Virginia Commonwealth University) and NiO NPs obtained from Dr K Ghosh
(Department of Physics, Missouri State University) were
4524
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synthesized as previously described.10 All NPs used were of
high purity (.97%) with size specifications in the nanoscale
(,100 nm). B4C, Fe2O3 and Cu nanopowders were purchased
from PlasmaChem GmbH (Berlin, Germany). MgO nanopowder was purchased from Sigma-Aldrich (St. Louis, MI,
USA). The NPs were washed with double-distilled deionized
water, 70% ethanol/water and ethanol and stored dry prior to
use. QuantiLum r-Firefly Luc (Ppy Luc, molecular weight
[MW] 61 kDa, 14.37 mg/mL) and the Luc Assay System
were obtained from Promega (Madison, WI, USA) and prepared and stored as described by Käkinen et al.32 They were
subsequently diluted to a 1 mg/mL (16.4 µM) stock solutions
in 0.01 mM PBS (pH adjusted to 7.8 with 0.01 N NaOH).
d -luciferin (high-performance liquid chromatography
[HPLC], 99% purity, monosodium salt) was purchased from
Pierce Biotechnology (Waltham, MA, USA) and suspended
in PBS (0.01 mM, pH 7.8) for a stock solution of 100 µg/mL.
Trypsin-EDTA (0.05%) was purchased from Life Technologies (Waltham, MA, USA), and GelCode Blue Safe Protein
Stain was purchased from Thermo Scientific (Waltham, MA,
USA). All steady-state fluorescence and bioluminescence
measurements (2-dimensional FDS [2D-FDS], intrinsic
fluorescence, PL) were conducted on SpectraMax i3x multimode microplate reader at 25°C (Molecular Devices, (San
Jose, CA, USA)) equipped with a Xenon flash lamp using
96-well black polypropylene microplates.

Intrinsic fluorescence measurements

Luc (1.64 µM in 0.01 M PBS, pH 7.8) excitation and emission
spectra were recorded between 250–310 nm (λem = 342 nm)
and 315–450 nm (λex = 295 nm), respectively. Excitation and
emission slit width was fixed at 5 nm. For studying NP alterations in Luc fluorescence, Luc samples were manually titrated
with successive 10 µL additions of NP solutions (100 µg/mL,
in double-distilled water [ddH2O]) to final NP concentrations of 10–100 µg/mL, with 11 samples in total. Luc–NP
samples were homogenized and incubated for 30 min prior
to measurement (25°C). Concentration and inner filter effects
were corrected by zeroing measurements of Luc with each
NP to identically prepare Luc-ddH2O samples (absent NPs).
The recorded spectra were corrected and analyzed using
SigmaPlot v12.3.

Fluorescence measurements of
d-Luciferin ± NPs
To verify that the NP complexation occurred to Luc and not
d-luciferin (substrate), intrinsic fluorescence of d-luciferin
was conducted as already described. d-luciferin (prepared as
outlined already) was incubated with 100 µg/mL or 10 µg/mL
International Journal of Nanomedicine 2018:13
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NP solutions, at a 1:1 ratio, for a final w/v ratio of 1:1 and
10:1. Excitation and emission spectra were recorded between
250–500 nm (λem = 530 nm) and 450–650 nm (λex = 390 nm),
respectively. Concentration and inner filter effects were corrected as already described.

analysis of d-luciferin was conducted in a similar manner
with extraction of Iem from instrumental Fem values; however,
because the photoexcitation and emission process is attributed
entirely to each molecule, the functional activation resides on
the excitation efficiency of d-luciferin, Iem⋅(AUC)−1.

Data analysis

Two-dimensional fluorescence difference
spectroscopy

Luc and d-luciferin fluorescence data spectra were obtained
from the instrument, and raw baseline measurements were
corrected by subtracting appropriate buffer background
fluorescence values using SpectraMax Pro 6.5 software.
Inner filter effects and instrumental variation were corrected by Luc or d-luciferin standard curve of fluorescence
(Fem) at λex = 280 nm and λex = 295 nm. This was converted
into corrected intensity values (Iem) using the well-known
Lambert–Beer’s law:
I em = ln (10)⋅I ex ⋅ε280 ⋅C⋅1



(1)

where Iex is the incident excitation intensity, ε is the molar
absorption coefficient for Luc (3.92×104 M−1cm−1, 280 nm)
or d-luciferin (6.29×103 M−1cm−1, 280 nm) and C is the
concentration of the fluorophore. Fluorescence emission is
proportional to number of excited states present in solution.
The standard curve (C1) was used to obtain the concentration of fluorophore present in the sample wells (C2) for the
abovementioned corrected intensity values.
I em (ref)
I em (sample)

=

C1
C2

(2)


The Trp emission spectra, including the wavelength
(max λem) at which fluorescence intensity is maximal (Imax)
is highly sensitive to changes in local Trp microenviorment.
Integrated fluorescence intensity, AUC, computed as the area
under the curve, is a measure for the relative fluorescence
quantum yield and indicates changes in the overall protein
environment.37 For each spectra, Luc fluorescence (λex =
295 nm) was integrated between 300 and 380 nm using the
Gaussian curve fitting function in SigmaPlot v13.0. Fluorescence ratio intrinsic basis states analysis (FRIBSTA) utilizes
the Iem, Imax and AUC to give a fractional area spectrum, useful
for comparing the effects of denaturants on protein stability and conformation.38 Accordingly, Luc-NP spectra were
normalized to the Luc-only spectra and plotted as Iem/AUC
or ΔImax/AUC.27 This was done for better interpretation of the
overall photochemical excitation and de-excitation processes
attributed to Luc possessing dual-Trp residue. Fluorescence
International Journal of Nanomedicine 2018:13

2-D FDS measurements were run according to specifications outlined previously39 with modifications. Fluorescence excitation (λex, 250–310 nm) and emission (λem,
280–400 nm) wavelengths of Luc were scanned at 2 nm
increments with 9 nm and 15 nm slit widths for λex and
λem, respectively. The measured value was corrected for
background fluorescence and the resulting values were
plotted as fluorescence emission vs excitation sensitivity,
measured in relative fluorescence units (RFU).

Bioluminescence spectra and kinetic
measurements of Luc with/without NPs
Ppy Luc bioluminescence spectra were conducted as
detailed by manufacturer’s instructions and described by
Käkinen et al.32 Luc kinetic and bioluminescence experiments were conducted using 20 µL of 0.05 mg/mL Luc
(0.82 µM) and 100 µL of reconstituted Luc reagent (LR)
in 96-well opaque polypropylene microplates. Signal was
recorded on a SpectraMax i3x multi-mode microplate
reader equipped with LED capability. Instrument sensitivity
was standardized using serial dilution of Luc samples
(50 µM–5×10−9 µM) with 100 µL LR. Initial bioluminescence spectra were measured between 450 and 750 nm with
150 ms integration at pH 7.8 and a temperature of 25°C.
The estimated mixing time was 15 s. Kinetic measurements were recorded directly after initial bioluminescence
(t0 = 60 s) over 600 s at 21 data points. Bioluminescence
intensity (relative light units [RLU]) readings were measured between 450 and 750 nm with 150 ms integration. For
NP-mediated alterations in Luc bioluminescence and kinetics, the bioluminescence spectra (t0 = 15 sec) and kinetic
readings (t0 = 60 sec) were recorded identically (as discussed
already) with pre-incubated Luc–NP mixtures at a 1:1 w/v
and 10:1 w/v ratio, respectively. Briefly, for the 1:1 w/v
Luc–NP mixture, 100 μL Luc (100 µg/mL) was added to
100 µL of homogenized NP (100 μg/mL) and incubated
under mild agitation (30 min, 25°C). The 10:1 w/v Luc:NP
mixtures were prepared identically with a 10-fold dilution
of the 100 µg/mL NP samples. Final Luc concentration
in Luc–NP samples was 0.05 μg/mL for all trials.
submit your manuscript | www.dovepress.com
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Immediately prior to measurements, 20 µL of either 1:1 w/v or
10:1 w/v Luc–NP mixtures were added to 100 µL of LR.
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Thin layer chromatography (TLC)
NP solutions with a concentration of 10 mg/mL in water were
prepared for ZnO, Cu, Co3O4, NiO, MgO, Si3N4, B4C and Fe2O3.
A saturated amino acid solution was prepared by adding amino
acids – lysine (Lys), glutamine (Glu), arginine (Arg), histidine
(His), tyrosine (Tyr) and threonine (Thr) – to 1 mL ddH2O.
Spotting solutions of amino acid and NPs were prepared in a
1:1 ratio by volume. In total, 1 µL of the mixture was applied
to a 13×19 cm TLC plate. The plate was allowed to dry and
placed in 10 mL of elution buffer (9:1 ratio of ethanol: acetic
acid [1 M]). The plate was left for 1 hour to allow the eluent to
elute up the plate. This plate was dried, sprayed with ninhydrin
staining solution and placed in a drying oven at 60°C for 10
minutes. Possible interactions/reactions between the amino
acids and NPs were determined by comparing Rf values.

Limited proteolysis with trypsin
To investigate the structural perturbation of Luc in the presence of NP complexation, limited proteolysis by trypsin was
accomplished. Briefly, Luc–NP samples were prepared at a
1:1 w/v ratio (0.5 mg/mL) with a final volume of 10 μL, which
were homogenized, centrifuged and incubated for 5 min at
25°C. The Luc–NP samples were incubated with 2 μL trypsin
(0.05% w/v) for the specified time periods (5 min, 15 min,
30 min and 60 min). Samples were run on sodium dodecyl
sulfate polyacrylamide gel electrophoresis (SDS-PAGE)
(100 V, 2 hours) and visualized using GelCode Blue Safe
Protein. Gels were imaged with a BioRad Molecular Image
Gel DocXR+ and analyzed with Image Lab software.

Luc–NP binding
To determine the quantity of Luc binding to NPs, 1 mg/mL
NPs and 0.5 mg/mL Luc were added to a final volume of 30 µL
and spun down for 1, 2 and 3 hours at 14,000 rpm at 4°C. The
quantity of protein in the supernatant unbound to the NPs was
obtained using Nanodrop 8000 spectrophotometer.

Examination of the effect of NPs on the
secondary structure of Luc
The secondary structure of untreated Luc and Luc–NP
mixtures was examined by CD spectroscopy (Chirascan;
Applied Photophysics Ltd., Leatherhead, UK). Luc solution
was prepared to a concentration of 200 µg/mL. Cu and B4C
NP solutions were prepared in deionized water with two different concentrations, 200 µg/mL and 20 µg/mL. Luc–NP
solutions with 1:1 and 10:1 ratios (Luc: NP, w/w) were then
4526
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prepared by mixing equal amounts of Luc and NP solutions.
Prior to mixing, NP solutions were homogenized with a
probe sonicator (VCX 130; Sonics & Materials, Inc., Newtown, CT, USA) for 2 min at 50% amplitude. The Luc–NP
mixtures were incubated under ambient conditions at 200
rpm for 30 min and examined using CD spectroscopy. The
final concentration of Luc in every CD sample was 100 µg/
mL, and the volume of each sample was 200 µL. CD in the
UV range (200–260 nm) was monitored with a 0.1 mm path
length quartz cell at ambient temperature. The CD spectra
were recorded with a step size of 1.0 nm, bandwidth 0.5 nm
and an averaging time of 3.0 s. CD spectra processing and
background subtractions were performed using Pro-Data
Viewer software (Applied Photophysics Ltd.). The CD data
were expressed in terms of molar residue ellipticity, [Ɵ], in
deg cm2 dmol−1. The distribution of secondary structures was
estimated from the obtained CD spectra by the Dichroweb
software package42–44 with the K2D algorithm. A total of six
samples were measured, and all data were presented as mean
± standard deviation. Data were compared using a Student’s
t-test with equal variances. A value of P,0.05 was considered statistically significant.

MTT assay
3T3 mouse fibroblast cells (American Type Culture Collection
[ATCC]) were seeded on a 96-well plate with 5,000 cells/well
and allowed to grow for 24 hours in DMEM with 10% FBS
and 1% penicillin/streptomycin. After 24 hours, the medium
was changed and the metal oxide treatments were added
(Fe2O3, NiO, MgO, B4C, ZnO and Cu), all at a concentration of
200 µg/mL in the same DMEM solution as before. Each treatment was tested on four sample wells. There were also four
wells with cells that did not receive treatment and four wells
that did not get any cells. After 24 hours with the treatment,
the treatment was removed and the wells were rinsed with PBS
and then a 1:20 mix of MTT: indicator-free DMEM was added
to each well with 110 µL per well and left to metabolize for
5 hours in the incubator. After 5 hours, 85 µL of the mixture
was removed from each well and 75 µL of dimethyl sulfoxide
was added to each well to solubilize the crystals. The plate
was then put on an orbital shaker at 37°C at 175 revolutions/
minute. After 15 minutes on the orbital shaker, the plate was
then read on a Synergy H1 Hybrid Multi-Mode Microplate
Reader for absorbance at a wavelength of 562 nm.

Results
Transmission electron microscopy confirmed the NP size
and morphology prior to the binding of Luc, which was
demonstrated by the particle size and zeta potential (ZP)
International Journal of Nanomedicine 2018:13
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Table 1 Physical characteristics of NPs before and after binding
of Luc

Table 2 Data comparison on the maximal fluoresence emission,
intensity and AUC

NP ± Luc

Size (nm)

Zeta potential (mV)

PDI

NP

Max λem (nm)(a)

ΔImax (%)

ΔAUC (%)

ZnO
Cu
B4C¥
Fe2O3
MgO
NiO

138, 1143
124, 174
163, 556
256, 1043
272, 311
56, 523

25.3, −15.5
13.5, −13.6
−32.5, −16.2
24.5, −11.8
17.8, −19.7
48.3, −18.2

0.16, 0.35
0.86, 0.33
0.16, 0.4
0.33, 0.58
0.57, 0.36
0.12, 0.36

ZnO
B4C
Cu
Fe2O3
MgO
NiO

341 ± 2
340 ± 4
338 ± 7
340 ± 2
342 ± 4
341 ± 2

67.87
83.98
85.34
3.96
−2.00
43.36

66.55
86.82
84.26
7.25
1.76
45.61

¥

Notes: ¥A TEM analysis was previously reported for ZnO and B4C NP, but was
repeated here to confirm nanoscale particles for all compositions studied prior
to binding protein.10,36 DLS, PDI and ZP analysis of the NPs before (left value)
and after introduction of Luc (right value). The NP concentration range was
7.3–24 mM.
Abbreviations: NPs, nanoparticles; Luc, luciferase; TEM, transmission electron
microscopy; PDI, polydispersity index; ZP, zeta potential.

analysis as shown in Table 1. Furthermore, the same
techniques were used to characterize the NPs after binding
with Luc. As expected, interactions between these NPs and
Luc protein caused an increase in hydrodynamic diameter
for all NPs (Table 1).
The changes in the NP size and ZP demonstrate
protein–NP interaction consistent with a prior study with
ZnO NPs.18 The decrease in polydispersity index for Cu
and increase in ZP for B4C in the presence of Luc suggest a
fundamental difference in their physicochemical interaction
and were explored further for their impact on Luc enzyme
structure-function by 2-D FDS and 2-dimensional photoluminescence difference spectroscopy (2-D PLDS), as described
further in the following text.
2-D FDS can be used to measure protein–NP interaction;39
here, it was performed comparatively by plotting the change
in intensity and AUC for Luc as a function of the NP type
to which it was exposed (Figure 1).
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±
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Figure 1 2-D FDS spectrum of Luc alone and Luc in the presence of Cu NPs at 25°C
in 0.01 M PBS (pH 7.8). The y axis represents Iem/AUC in relative absorbance units
RFU or the change in ΔImax/AUC (%). The x axis represents emission wavelength
(315–455 nm) (λex = 295 nm). The data are tabulated in Table 2 for all NPs at
50 µg/mL NP. The black line represents Iem/AUC (corresponding to the black axis)
and the orange line represents ΔImax/AUC (%) (corresponding to the orange axis).
Abbreviations: 2-D FDS, 2-dimensional fluorescence difference spectroscopy;
Luc, luciferase; NPs, nanoparticles; AUC, area under the curve; RFU, relative
fluorescence units.

International Journal of Nanomedicine 2018:13

Note: aMean±SD.
Abbreviations: AUC, area under the curve; NP, nanoparticle.

As shown in Figure 1, a concentration-dependent change
in the 2-D FDS pattern was observed, where the most overt
change in both maximal fluorescence intensity (Imax) and
AUC was for Cu-NP. The remaining data of the series by
this criterion are summarized in Table 2.
As summarized in Table 2, B4C and Cu NPs caused the
greatest change in 2-D FDS as reflected in the maximal
fluorescence intensity, its change (ΔImax) and AUC analysis.
While the fluorescence wavelength was unchanged, Imax and
AUC changes are presumed to be due to Trp residues in the
flexible hinge region, implying an excellent in situ read out
of the protein’s conformation.27,28
The dramatic change in AUC fluorescence for Cu and
B4C suggested potential conformational changes induced
in Luc upon interaction with these NPs. To further examine
this, limited trypsin digestion was performed followed by
protein gel electrophoresis analysis. Here, degradation is
being caused by trypsin proteolysis. The rate of proteolysis
is expected to increase for an unfolded versus a folded protein (Figure 2).
As shown in Figure 2A and B, Luc–Cu samples degraded
faster than Luc–B4C or Luc-only controls. These data are
consistent with the hypothesis that absorption of Luc to Cu
NPs causes partial unfolding and, thus, greater accessibility
for cleavage. Similar to controls, B4C NPs showed an initial
band migrating at an apparent MW of approximately 45 kDa.
Although it was not possible to unambiguously identify the
Luc fragment corresponding to this band from the electrophoresis analysis, the trypsin cleavage positions capable of
producing such a fragment are limited. Trypsin cleavage
occurs only at Lys (K) or Arg (R) residues, with the neighboring environment determining the probability of any particular
cleavage. Notably, cleavage at a particular site implies that
this site is accessible to trypsin and not completely occluded
by contact with the NPs. We applied the Cleavage Prediction
with Decision Trees algorithm40 to determine the probability
of cleavages that yield fragments with a mass of 45±4 kDa.
For the shortest durations shown in Figure 2A and B, it can
be assumed that most Luc molecules are uncleaved or have
submit your manuscript | www.dovepress.com
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Figure 2 SDS-PAGE analysis of Luc tryptic digests in presence of (A) Cu or (B) B4C NP. The arrow denotes the lane corresponding to a mass of 45±4 kDa, assigned based
on prior gels relative to molecular weight markers and the known molecular weight of Luc in the main band above. (C) Possible locations of a single cleavage of Luc by trypsin
resulting in the observed 45±4 kDa fragments. Luc (PDB ID: 1LCI) is shown in a secondary-structure representation and cleavage locations are highlighted by spheres. The
color of the spheres indicates the cleavage probability as predicted by the algorithm,40 with green, yellow and red, respectively, denoting probabilities P.0.85, 0.85#P#0.6
and P,0.6. (D) Cleavage locations that preclude formation of 45±4 kDa fragments (magenta) and those locations that are consistent with the formation of 45±4 kDa
fragments by one or more cleavage events (yellow).
Abbreviations: SDS-PAGE, sodium dodecyl sulfate polyacrylamide gel electrophoresis; Luc, luciferase; NP, nanoparticle.
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Figure 3 Effect of NPs on Luc kinetics and PL spectra. (A) Time dependence of Luc activity in the presence of Fe2O3 and Cu NP. (B) Luminescence as a function of
wavelength for Luc control and in the presence of Cu, Fe2O3 and B4C NP.
Abbreviations: NPs, nanoparticles; Luc, luciferase; PL, photoluminescence.

been cleaved only once. Figure 2C shows the 15 locations of
Luc where a single cleavage can yield 45±4 kDa fragments,
occupying just two regions of the protein. The Luc image
is based on the x-ray-derived structure (Protein Data Bank
identifier [PDB ID]: 1LCI)23 with atomic coordinates for
missing residues as estimated by MODELLER software.41
Based on protected regions of the protein not being cleaved,
these results seem to imply that either residues 372–439 or
residues 112–155 remain accessible to trypsin when Luc is
adsorbed to B4C NP. Even when multiple cleavage events are
taken into account, there remain some limitations on where
cleavage can occur to form 45±4 kDa fragments, as shown
in Figure 2D. We hypothesize that cleavage of the relatively
independent C-terminal domain23 at residue 437 or 439 is a
major contributor to the band at ~45 kDa.
Next, the impact of protein–NP interaction on Luc enzyme
activity was investigated by 2-D PLDS. The rapid kinetics of
the enzyme was monitored 60 seconds after the injection of
the Luciferin substrate. The decay rate, PL spectra and AUC
were plotted over the course of approximately one half-life
(11 minutes or 660 seconds), as shown in Figure 3A and B.
As shown in Figure 3, and consistent with enzyme denaturation by Cu NPs, nanobiocatalysis was delayed causing a
negative decay rate within the rapid timespan of the experiment (60–660 seconds). The AUC increased accordingly.
The decay rate for Fe2O3 NPs was also negative and unique
relative to the other NPs. Quite surprisingly, in the presence
of B4C NPs, no PL was catalyzed. These data suggested that
the impact of nano-bio interaction on enzyme function may
be more complicated than altering protein conformation.
These data are summarized in Table 3.
The data in Table 3 when taken comparatively suggest
some plausible mechanistic insight. In addition to partial
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protein denaturation causing loss of activity (as suggested
in Figure 2), another potential explanation for the delayed
onset and fine structure observed in the PL spectra for Cu
and Fe2O3 is interaction between the NPs and the d-luciferin
substrate rather than the protein itself. Given the intrinsic
fluorescence of the luciferin substrate, its quantum efficiency
could be obtained by integrating AUC for its excitation and
emission in the presence of the NPs as per the following
equation:
∞

Relative φf

∫
=
∫

0

I (λ em )dt

∞

0

I (λ ex )dt

(3)


where relative quantum yield, φf , and integrated intensity,
I, were used to quantitatively assess overall changes in the
energy transfer efficiency (φf ) of d-luciferin. These plots were
recorded at two different NP concentrations (0.1 or 0.01 g/mL).
As shown in Figure 4, for most NPs, the change in quantum
Table 3 Effect of NPs on Luc kinetics and PL spectra
NP

λem (nm)¥

PL decay rate
(RLU/min)

Δ in activity
(%)£

ZnO
Cu

545 ± 5
545 ± 5

9.17×103
−7.67×103*

45.8
271.0

B4C
Fe2O3

ND
550 ± 5

ND
−3.50×101*

ND
31.3

MgO
NiO

560
545 ± 5

2.67×104
4.33×103

20.4
49.1

Notes: Luc control λem = 555–562 nm, 3.17×104 RLU/min, change in activity
(0% control). Δ in activity curve compares AUC for activity relative to control.
¥
Values reported as mean ± SD (n = 4). *Negative decay rate (luminescence/time
$0). £Time period from initial luminescence (t0 = 60 seconds) to final luminescence
(tf = 660 seconds).
Abbreviations: NPs, nanoparticles; Luc, luciferase; PL, photoluminescence; RLU,
relative light units; AUC, area under the curve; ND, not detected.
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Figure 4 Change in emission–excitation of d-luciferin in the presence or absence
of NPs. The relative φf (AUC) values are normalized such that the emission and
excitation AUC values of the d-luciferin samples are 1. NP concentrations are
indicated in mg/mL (0.1 and 0.01 mg/mL). The dotted line indicates the quadratic fit
to the AUC data.
Abbreviations: NPs, nanoparticles; AUC, area under the curve.

yield from the luciferin-only control was negligible (|∆φf|#0.05).
The exception is Cu NPs, particularly at the 0.1 g/mL
concentration, for which φf = 0.76. ZnO NPs also slightly
impeded d-luciferin photoexcitation, with φf ≈ 0.9 at the two
concentrations considered. Altogether, these data suggest that
for most NPs, conformational changes in the enzyme due to interaction with the NPs underlie the changes in enzyme activity.
One major difficulty in understanding the physicochemistry of interactions between proteins and NPs is that the
atomic-scale structure of the NP surfaces in an aqueous
environment where they encounter enzymes are not well
characterized. To approximate the chemical structure of the
NP surfaces, molecular dynamics simulations were used to
reconstruct ZnO, Cu and B4C surfaces in water under ambient
conditions. As shown in Figure 5A, 79% and 73% of the undercoordinated Zn and O atoms of the pristine ZnO{1010} surface
became capped with OH or H groups, respectively. Similarly,
under-coordinated atoms of the B4C surface underwent chemical
reactions with water to yield boranes and oxygen-containing
boron moieties. Notably, 96% of surface boron atoms bound
to carbon formed boronic acid moieties (Figure 5B) or, more
rarely, borinic acid groups. Surface boron atoms not bound to
carbon tended to form borane or diborane motifs. The Cu{111}
surface, on the other hand, underwent much less modification.
Only 29% of the under-coordinated surface atoms formed
covalent bonds to water molecules (Figure 5C), leaving a
majority of the Cu atoms free to make contact with solutes.
In the experiments, these particles are stabilized by 3% oleic
acid, which may impact water behavior at the surface.
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Another advantage of Luc as a model enzyme is that
its active site has also been well characterized.46 The key
Trp moieties making conformational changes in the protein
induced by NP interaction are measurable by 2-D FDS as
already mentioned. A model for the substrate binding site
is shown in Figure S1.25,26 In addition to glutamate and Tyr
shown in the inset, site-directed mutagenesis and comparative
homology studies also suggest the importance of His, Thr and
Lys.28–30,40 Altered chromatographic elution has previously
been used to gauge interactions to derivatized silica, and
was used similarly here to investigate NP interaction with
these different amino acids by TLC (Figure S2). The greatest
migrational difference (% control Rf) was seen for Lys that
occurred to all NPs, likely indicative of ionic interactions.
However, migration differences were seen for Glu and Thr,
indicating that hydrogen bonding or polar type interactions
may also contribute to interaction. Minor migration differences for Tyr and His do not rule out non-polar stabilizing
interactions but would need to be extended to other non-polar
amino acids to better determine their effect.
To confirm conformation changes suggested by the fluorescence, bioluminescence, gel and biochemical activity data
by Cu and B4C NP, a final CD experiment was conducted.
Figure 6A shows the CD spectra of Luc–Cu mixture with
1:1 and 10:1, and Figure 6B presents their secondary structure
distribution. Untreated (native) Luc was used as a control.
The untreated Luc had two negative ellipticity values at
208 and 222 nm and contained 39.00% α-helix, 5.67%
β-sheet and 55.17% random coil structures. The Luc–Cu
mixtures, on the other hand, showed significant reduction in
ellipticity values. The α-helix structure of the Luc–Cu mixture with 10:1 ratio was decreased from 39.00% to 25.67%,
together with an increase of β-sheet from 5.67% to 24.67%.
Particularly, the α-helix contents of the Luc–Cu mixture
with 1:1 ratio were significantly decreased as compared with
untreated Luc (18.23%), along with a substantial increase of
β-sheet (33.33%). Figure 6C and D displays the CD spectra
and the secondary structure distribution of Luc–B4C mixture
with two different ratios, respectively. The CD spectra of
Luc–B4C mixture with 10:1 and 1:1 ratio showed remarkably
lower ellipticity values as compared with untreated Luc, and
the corresponding secondary structure distribution showed
a trend similar to that of Luc–Cu mixture. For 1:1 ratio,
however, B4C NPs seemed to induce more conformational
changes of Luc than Cu NPs. Overall, it was apparent that
Cu and B4C NPs disturbed the secondary structure of Luc,
and the degree of disturbance increased as the concentration
of NPs increased.
International Journal of Nanomedicine 2018:13
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Figure 5 Reconstruction of pristine nanomaterial surfaces in the presence of water using reactive molecular dynamics simulations. The images on the left show a top-down
view of the surface after equilibration in vacuum, while the images on the right show the same surfaces after 1 ns of reactive molecular dynamics in contact with water. The
images on the right are side views of a select portion of the surface, revealing the bonding topology of the chemical modifications. The location of the aqueous phase above
the surface is indicated. (A) The ZnO{1010} surface becomes almost completely populated by zinc hydroxides. (B) The B4C{1011} surface forms boronic acid groups as well
as borane moieties. (C) The Cu{111} surface accumulates some chemisorbed water molecules, but many under-coordinated Cu atoms remain exposed.
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Figure 6 (A) CD spectra of Luc–Cu mixtures with 1:1 and 10:1 ratios. (B) Distribution of secondary structure estimated by the K2D algorithm provided by DichroWeb.42–44
(C) CD spectra of Luc–B4C mixtures with 1:1 and 10:1 ratios. (D) Distribution of the secondary structures. Untreated (native) Luc was used as a control. *Significant
difference between untreated Luc and Luc–NP mixtures (n = 6, P,0.05).
Abbreviations: CD, circular dichroism; Luc, luciferase; NP, nanoparticle.

Taken together, the CD data suggest that Cu and B4C
NPs induce substantial structural rearrangement in the Luc
protein. These data are consistent with the prior fluorescence
and luminescence measurements. Although the biophysical
or biochemical impact of the nano-bio interaction was the
driving force behind this investigation, the NP series were
tested by MTT assay on NIH3T3 cells. The B4C NPs absorb
in the 562 nm range, interfering with this assay. The cell
viability of the remaining NPs had the following ranking:
MgO.Fe2O3.NiO.ZnO.Cu, where only Cu and to a
lesser extent NiO and ZnO were significantly different than
MgO, Fe2O3 or controls. Given these data, the NiO and ZnO
were compared to MgO in the mouse splenocyte assay,45
where only NiO significantly altered the P1/P2 ratio after
propidium iodide staining and flow cytometry analysis (data
not shown).
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Conclusion
In conclusion, here comparative functional nano-bio analysis
was performed. A change in fluorescence intensity was
observed in the presence of all NPs tested. The largest change
in both these parameters was seen with Cu NPs and B4C NPs.
These NPs in particular also greatly impact the enzyme kinetics and bioluminescence output of the enzyme, with Cu NPs
prolonging the kinetics and B4C NPs greatly inhibiting bioluminescence. Furthermore, trypsin digestion studies show that
B4C NPs protect Luc from degradation, whereas the presence
of Cu NPs increases the rate of degradation with virtually no
intact enzyme remaining after only a short period of incubation. These data suggest that these two NPs in particular have
very different conformational effects on the enzyme. The
increase in UV absorbance seen in the presence of Cu NPs,
as contrasted with all other NPs where sedimentation of the
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Luc bound NPs and loss of UV absorbance in the supernatant
occurred, is also consistent with partial protein unfolding as
a consequence of Cu–NP interaction (Figure S3). Certainly
cerium oxide and ZnO have similarly been shown to induce
conformational changes on thermal denaturation when
monitoring Trp fluorescence or UV absorbance changes to
fibrinogen and albumin similarly.17 By contrast, the fine structure observed in the PL spectra in the presence of Fe2O3 NPs
and the quantum efficiency energy change in the presence of
ZnO NPs suggests that the mechanisms of these NP effects on
enzymes may be more complicated and may involve interactions between the NPs and substrate (in this case, d-luciferin),
which need to be further explored. Finally, the inhibition seen
by B4C appears to be unique in comparison to the other NPs,
where no bioluminescence was detected even though this NP
protects against trypsin digestion and does appear to induce
conformation change as seen by 2-D FDS and CD. In this case,
no photoelectron disturbance or quantum efficiency change
in the presence of substrate was seen. For the most part, the
metal or metal oxide surfaces appear to behave similarly in
water where enzyme interaction causes an increase in NP size
and a decrease in ZP consistent with their protein association.
However, here again, B4C behaves very differently and in
this case the molecular dynamics simulations of its surface
shed some insight suggesting that, in water, boron surfaces
convert to boronic acid, which likely leads to hydrogenbonding interactions with protein. This is consistent with
the ZP change. Whereas the ZP of all other materials shifted
to the negative upon protein interaction, the ZP of B4C NPs
shifted to the positive. Chromatographic interactions with
amino acids, particularly with glutamate, were quite distinct
between B4C and Fe2O3 again suggesting the fundamentally
different physicochemical behavior of B4C versus the wellcharacterized Fe2O3 metal oxide NPs. These results suggest
that this panel of NPs, particularly B4C and Cu as well as Fe2O3
NP, should be further evaluated against disease-relevant10,18,39
and physiologically significant enzymes.
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Figure S1 Luc active site showing the luciferin substrate binding site.
Abbreviations: Luc, luciferase; Glu, glutamate; Tyr, tyrosine; Ser, serine; Lys, lysine; Asp, aspartate.
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Figure S2 TLC migration of amino acids and the change in migration distance relative to the solvent front (Rf) in the presence of each NP.
Abbreviations: TLC, thin layer chromatography; NP, nanoparticle; Lys, lysine; Glu, glutamate; Arg, arginine; His, histidine; Tyr, tyrosine; Thr, threonine.
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Figure S3 Binding capacity of Luc to NP surface. Cu NPs cause conformational changes leading to higher OD reading, and subsequently concentration in the supernatant.
Abbreviations: Luc, luciferase; NPs, nanoparticles.
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